Literature DB >> 3895028

Stereotactic surgery for mass lesions of the midbrain and pons.

R J Coffey, L D Lunsford.   

Abstract

Appropriate treatment for intracranial mass lesions depends upon accurate histological diagnosis. Although both advanced generation computed tomographic and magnetic resonance scanners can detect small lesions within the brain stem, only the combination of these advanced imaging tools with stereotactic instrumentation permits safe and accurate pathological diagnosis of such lesions. We present the results of 13 operations performed on 12 patients with mass lesions of the pons and mesencephalon. A definitive diagnosis was obtained in all patients. Aspiration of necrotic tumors (3 patients), neoplastic or benign cysts (2 patients), and chronic hematomas (2 patients) resulted in immediate neurological improvement in 7 of these 12 patients. No morbidity or mortality related to surgery occurred in this series. Both the preoperative clinical and radiographic diagnoses were erroneous in 6 patients so that accurate histological diagnosis indeed altered subsequent therapy. A transfrontal approach to the midbrain and a transcerebellar approach to the lateral pons are described. The importance of accurate diagnosis, the possibility of definitive therapy in selected patients, and the encouraging benefits and safety of stereotactic surgery indicate that empiric treatment of mass lesions of the midbrain and pons is no longer justified.

Entities:  

Mesh:

Year:  1985        PMID: 3895028     DOI: 10.1227/00006123-198507000-00003

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  27 in total

1.  Neurosurgery with craniotomy and CT stereotactic guidance in the treatment of intracerebral space-occupying lesions.

Authors:  J F Hirsch; C S Rose; A Pierre-Kahn; D Renier; E Hoppe-Hirsch
Journal:  Childs Nerv Syst       Date:  1990-09       Impact factor: 1.475

2.  Stereotactic Transcerebellar Approach to Pontine Lesions through the Middle Cerebellar Peduncle.

Authors:  P Parker; M F Levesque; J Bittoun; D Doyon; M Tadie
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

3.  Accuracy of stereotactic brain tumor biopsy: comparison of the histologic findings in biopsy cylinders and resected tumor tissue.

Authors:  W Feiden; U Steude; K Bise; O Gündisch
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

4.  Stereotactic anatomy of the posterior cranial fossa. A study of the transcerebellar approach to the brainstem.

Authors:  A Gonçalves-Ferreira
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

5.  Stereotaxic biopsy of brain-stem tumours in children.

Authors:  W H Chhang; V K Kak; A K Banerjee; A Rajwanshi
Journal:  Childs Nerv Syst       Date:  1990-11       Impact factor: 1.475

Review 6.  Brainstem haematomas: review of the literature and presentation of five new cases.

Authors:  J R Mangiardi; F J Epstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-07       Impact factor: 10.154

7.  Indications for stereotactically-aided differential diagnosis: the neurologist's view.

Authors:  J Hildebrand
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

8.  Tectal plate gliomas. Part I: Microsurgery of the tectal plate gliomas.

Authors:  C Lapras; L Bognar; F Turjman; E Villanyi; C Mottolese; C Fischer; A Jouvet; J Guyotat
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

9.  Stereotactically-guided biopsies of brainstem tumors.

Authors:  F Chico-Ponce de León; M Perezpeña-Diazconti; E Castro-Sierra; F J Guerrero-Jazo; L F Gordillo-Domínguez; R Gutiérrez-Guerra; T Salamanca; G Sosa-Sainz; B L Santana-Montero; A DeMontesinos-Sampedro
Journal:  Childs Nerv Syst       Date:  2003-05-06       Impact factor: 1.475

10.  Postoperative management of patients after stereotactic biopsy: results of a survey of the AANS/CNS section on tumors and a single institution study.

Authors:  Ronald E Warnick; Lynn M Longmore; Christian A Paul; Laurie A Bode
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.